RAS mutations in benign epithelial tumors associated with BRAF inhibitor treatment of melanoma

Jessica C. Hassel; Leopold Groesser; Eva Herschberger; Wilko Weichert; Christian Hafner

doi:10.1038/jid.2014.360

RAS mutations in benign epithelial tumors associated with BRAF inhibitor treatment of melanoma

Jessica C. Hassel
, Leopold Groesser
, Eva Herschberger
, Wilko Weichert
, Christian Hafner

Universitätsklinikum Heidelberg
Klinikum der Universität Regensburg und Medizinische Fakultät

Research output: Contribution to journal › Letter › peer-review

6 Scopus citations

Original language	English
Pages (from-to)	636-639
Number of pages	4
Journal	Journal of Investigative Dermatology
Volume	135
Issue number	2
DOIs	https://doi.org/10.1038/jid.2014.360
State	Published - 13 Feb 2015
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1038/jid.2014.360

Cite this

@article{fab35b8e17f144648bb2b14cac0e1040,

title = "RAS mutations in benign epithelial tumors associated with BRAF inhibitor treatment of melanoma",

author = "Hassel, \{Jessica C.\} and Leopold Groesser and Eva Herschberger and Wilko Weichert and Christian Hafner",

note = "Funding Information: We thank Roland Penzel, Institute for Pathology, University Hospital Heidelberg, for the investigation of oncogenic HPV in six samples, Ian Davis for English revision of the manuscript, and Anja Heid for picture editing. JCH is a member of the committee for cutaneous side effects of the DeCOG and was supported by the Olympia-Morata grant of the Medical Faculty, University of Heidelberg.",

year = "2015",

month = feb,

day = "13",

doi = "10.1038/jid.2014.360",

language = "English",

volume = "135",

pages = "636--639",

journal = "Journal of Investigative Dermatology",

issn = "0022-202X",

publisher = "Elsevier B.V.",

number = "2",

}

TY - JOUR

T1 - RAS mutations in benign epithelial tumors associated with BRAF inhibitor treatment of melanoma

AU - Hassel, Jessica C.

AU - Groesser, Leopold

AU - Herschberger, Eva

AU - Weichert, Wilko

AU - Hafner, Christian

N1 - Funding Information: We thank Roland Penzel, Institute for Pathology, University Hospital Heidelberg, for the investigation of oncogenic HPV in six samples, Ian Davis for English revision of the manuscript, and Anja Heid for picture editing. JCH is a member of the committee for cutaneous side effects of the DeCOG and was supported by the Olympia-Morata grant of the Medical Faculty, University of Heidelberg.

PY - 2015/2/13

Y1 - 2015/2/13

UR - https://www.scopus.com/pages/publications/84925348149

U2 - 10.1038/jid.2014.360

DO - 10.1038/jid.2014.360

M3 - Letter

C2 - 25118623

AN - SCOPUS:84925348149

SN - 0022-202X

VL - 135

SP - 636

EP - 639

JO - Journal of Investigative Dermatology

JF - Journal of Investigative Dermatology

IS - 2

ER -

RAS mutations in benign epithelial tumors associated with BRAF inhibitor treatment of melanoma

UN SDGs

Access to Document

Other files and links

Cite this